Sol_75N98026Q00369_Amd_0003.pdf

PDF 230 KB Posted

Attached to
NGS services to support clinical research
Solicitation number
75N98026Q00369
Issued by

About this file

This is a Request for Quotation (RFQ) issued by the National Institutes of Health, Office of Logistics and Acquisition Operations, for Next Generation Sequencing (NGS) services to support clinical and research activities related to bone marrow failure syndromes, including aplastic anemia and related disorders. The RFQ number is 75N98026Q00369/0003, issued on 05/15/2026 with a quotation deadline of 05/29/2026 at 0900 EDT. The period of performance runs from 06/01/2026 to 05/31/2027. This is not a small business set-aside. The solicitation is structured as a Combined Synopsis/Solicitation (Competitive) for a Hematology Profile Panel service with an anticipated volume of 144 samples total, classified under Product/Service Code Q301 (Reference Laboratory Testing). Quotations should be submitted to Nicholas Capobianco at the NIH OD office in Bethesda, Maryland.

The Government anticipates approximately 144 total samples throughout the period of performance, though samples may be shipped in multiple batches based on ongoing clinical and research requirements with no guaranteed batch quantities or shipment frequency. The contractor must propose sequencing panels and methodologies capable of covering clinically relevant genes associated with hematologic malignancies and bone marrow failure syndromes, including but not limited to UBA1, TERT, GATA2, CALR, FLT3, and NPM1. The contractor must maintain current CLIA certification, provide capability for automated extraction of both DNA and RNA from various tissue types, supply specimen shipment materials including shipping labels and transport materials, and provide reasonable logistical support for specimen coordination. Reports shall identify detected clinically relevant mutations with sequencing analysis accessible through a secure electronic reporting platform. The contractor must maintain appropriate safeguards for patient-sensitive information in accordance with applicable laws and regulations, with reports containing sensitive information accessible only through secure authenticated access methods. Applicable FAR clauses include 52.204-13, 52.204-18, 52.212-4, 52.212-5, 52.217-8, and 52.252-2, along with HHSAR 352.222-70.

View the file

Other files

File Type Posted
Sol_75N98026Q00369_Amd_0002.pdf PDF
Sol_75N98026Q00369_Amd_0001.pdf PDF
CSS_75N98026Q00369_0001.pdf PDF
Sol_75N98026Q00369.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

REQUEST FOR QUOTATION

(THIS IS NOT AN ORDER)

THIS RFQ IS IS NOT A SMALL BUSINESS SET-ASIDE

15. DATE OF QUOTATION

16. SIGNER

a. NAME (Type or print)

c. TITLE (Type or print)

b. TELEPHONE

AREA CODE

NUMBER

STANDARD FORM 18 (REV. 6/1995)

Prescribed by GSA-FAR (48 CFR) 53.215-1(a)

AUTHORIZED FOR LOCAL REPRODUCTION

Previous edition not usable

8. TO:

b. COMPANYa. NAME

c. STREET ADDRESS

d. CITY e. STATE f. ZIP CODE

9. DESTINATION

a. NAME OF CONSIGNEE

b. STREET ADDRESS

d. STATE e. ZIP CODE

7. DELIVERY

FOB DESTINATION

OTHER

(See Schedule)

10. PLEASE FURNISH QUOTATIONS TO THE

ISSUING OFFICE IN BLOCK 5a ON OR BEFORE CLOSE OF BUSINESS (Date)

IMPORTANT: This is a request for information and quotations furnished are not offers. If you are unable to quote, please so indicate on this form and return it to the address in Block 5a. This request does not commit the Government to pay any costs incurred in the preparation of the submission of this quotation or to contract for supplies or service. Supplies are of domestic origin unless otherwise indicated by quoter. Any representations and/or certifications attached to this Request for Quotation must be completed by the quoter.

11. SCHEDULE (Include applicable Federal, State and local taxes)

ITEM NUMBER

(a)

SUPPLIES/SERVICES

(b)

QUANTITY

(c)

UNIT

(d)

UNIT PRICE

(e)

AMOUNT

(f)

12. DISCOUNT FOR PROMPT PAYMENT

a. 10 CALENDAR DAYS (%) b. 20 CALENDAR DAYS (%) c. 30 CALENDAR DAYS (%) d. CALENDAR DAYS

NUMBER PERCENTAGE

NOTE: Additional provisions and representations are are not attached.

13. NAME AND ADDRESS OF QUOTER

a. NAME OF QUOTER

b. STREET ADDRESS

c. COUNTY

d. CITY e. STATE f. ZIP CODE

14. SIGNATURE OF PERSON AUTHORIZED TO

SIGN QUOTATION

PAGE OF PAGES

1. REQUEST NUMBER 2. DATE ISSUED 3. REQUISITION/PURCHASE REQUEST NUMBER 4. CERT. FOR NAT. DEF.

UNDER BDSA REG. 2

AND/OR DMS REG. 1

RATING

5a. ISSUED BY 6. DELIVER BY (Date)

NAME TELEPHONE NUMBER

AREA CODE NUMBER

c. CITY

5b. FOR INFORMATION CALL (NO COLLECT CALLS)

National Institutes of Health OD - Office of Logistics and Acquisition Operations 6100 Executive Blvd., Room 6B05 Bethesda, MD 20892-7511

75N98026Q00369/0003

NICHOLAS CAPOBIANCO

+10

000-000000

05/15/2026

05/29/2026 0900 ED

Multiple

The purpose of this COMBINED SYNOPSIS /

SOLICITATION (COMPETITIVE) is to obtain

Next Generation Sequencing (NGS) services to support clinical and research activities related to bone marrow failure syndromes, including aplastic anemia and related disorders.

Period of Performance: 06/01/2026 to

05/31/2027

1 144 EAHematology Profile Panel (144 Samples)

Product/Service Code: Q301

Product/Service Description: REFERENCE

LABORATORY

TESTING

Continued...

1 5

CONTINUATION SHEET

REFERENCE NO. OF DOCUMENT BEING CONTINUED PAGES

NAME OF OFFEROR OR CONTRACTOR

SUPPLIES/SERVICES

(B)

UNIT

(D)

UNIT PRICE

(E)

AMOUNT

(F)

OPTIONAL FORM 336 (4-86)

Sponsored by GSA FAR (48 CFR) 53.110

ITEM NO.

(A)

QUANTITY

(C)

NSN 7540-01-152-8067

75N98026Q00369/0003

The following FAR clauses and Provisions are applicable to this award.

FAR 52.204-13 System for Award Management

Maintenance (Oct 2018)

FAR 52.204-18 Commercial and Government Entity

Code Maintenance (Aug 2020)

HHSAR 352.222-70, Contractor Cooperation in

Equal Employment Opportunity Investigations

(Dec 2015)

FAR 52.212-4 Contract Terms and Conditions -In addition to all the applicable commercial

Products and Commercial Services (Nov 2023)

FAR 52.212-5 Contract Terms and Conditions

Required to Implement Statutes or Executive

Orders/Commercial Products and Commercial

Services (Jan 2025)

FAR 52.217-8 Option to Extend Services (Nov

1999)

FAR 52.252-2 CLAUSES INCORPORATED BY REFERENCE

Questions and Answers (Continued)

Solicitation No. 75N98026Q00369

The following additional questions were received regarding Solicitation No. 75N98026Q00369. The Government provides the following responses and clarifications.

Question 1:

How many total samples are included in this project?

Response:

The Government anticipates approximately 144 total samples during the period of performance.

Question 2:

Will the samples ship together in a single batch? If they will be sent in multiple shipments, could you please specify the number of batches and the sample count per batch?

Response:

Samples may be shipped in multiple batches throughout the period of performance based on ongoing clinical and research requirements. The Government cannot guarantee specific batch quantities or shipment frequency.

Question 3:

Could the Government provide additional details regarding the expected contents of the final report?

Response:

Reports shall identify detected clinically relevant mutations and provide sequencing analysis and reporting sufficient to support ongoing clinical and research activities. Reports shall be accessible through the contractor¿s secure electronic reporting platform.

Question 4:

Does the Government require a specific commercial gene panel or a custom-designed panel?

Response:

Offerors shall propose sequencing panels and methodologies capable of meeting the requirements identified in the solicitation, including coverage of clinically relevant genes associated with hematologic malignancies and bone marrow failure syndromes, including but not limited to UBA1, TERT, GATA2, CALR, FLT3, and NPM1.

Question 5:

Is CLIA certification required?

Response:

Yes. The contractor shall maintain current CLIA certification for performance of the required laboratory testing services.

Question 6:

The solicitation references automated extraction for both DNA and RNA. Please clarify whether RNA extraction is required.

Response:

Yes. The Government requires the capability to perform automated extraction of both DNA and RNA from various tissue types as described in the Statement of Work.

Question 7:

Could the Government clarify what is meant by ¿kits¿ and FedEx return labels?

Response:

The contractor shall provide materials necessary for specimen shipment and transport, including shipping labels and specimen transport materials.

Question 8:

What level of logistical support is required from the contractor?

Response:

The contractor shall provide reasonable logistical support associated with specimen shipment, receipt, and coordination necessary for performance of the required services.

Question 9:

Will samples be anonymized, and will personally identifiable information (PII) be provided?

Response:

The contractor shall maintain appropriate safeguards for protection of patient-sensitive information in accordance with applicable laws, regulations, and industry standards. Reports containing sensitive patient information shall be accessible only through secure authenticated access methods.

All other terms and conditions remain unchanged.

Request for quotations
Request number
Date issued
Requisition/purchase request number
CERT. FOR NAT. DEF. UNDER BDSA REG. 2 AND/OR DMS REG. 1
Issued by
For information call
Name
Telephone number
Area code
number
Deliver by (date)
Delivery
To:
Name
Company
Street address
City
State
Zip code
Destination
Name of consignee
Street address
City
State
Zip code
Please furnish quotations to the issuing office in block 5a on or before close of business
Schedule
Discount for prompt payment
10 calendar days (%)
20 calendar days (%)
30 calendar days (%)
Calendar days
Number
Percentage
Name and address of quoter
Name of quoter
Street address
County
City
State
Zip code
Signature of person authorized to sign quotation
Date of quotation
Signer
Name
Telephone
Area code
Number

Title

AUTHORIZED FOR LOCAL REPRODUCTION Previous edition not usable
Standard form 18 (Rev. 6/1995)

File details come from the government source that posted it. Updated .